US Patent 7135466 Quinoline and quinazoline derivatives and drugs containing the same
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 14 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Atushi Miwa0
Takayuki Furuta0
Terufumi Senga0
Teruyuki Sakai0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+331 characters)
Article
Patent abstract
There are provided compounds which can be used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy. The compounds are those represented by formula (I) or pharmacologically acceptable salts or solvates thereof:
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07135466 Quinoline and quinazoline derivatives and drugs containing the same US Patent 7135466 Quinoline and quinazoline derivatives and drugs containing the same
Infobox
Patent Number
07135466
Patent Number
7135466
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07135466 Quinoline and quinazoline derivatives and drugs containing the same
Infobox
Is a
Patent jurisdiction
Patent number
07135466
Date of patent
November 14, 2006
Patent application number
10168392
Date Filed
December 22, 2000
Patent primary examiner
Find more entities like US Patent 7135466 Quinoline and quinazoline derivatives and drugs containing the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
